To understand this further, we analyzed our targeted CRISPR screens in the 10 neuroblastoma cell lines (Fig. 2A), noticing the cell cycle regulator CDK4 knockout was the #2 ranked sensitization hit. The gene discussed is CDK4; the disease is neuroblastoma.